The TCGA CIN subtype was also notable for frequent EGFR amplification, including Erbb2 (HER2) (24% in CIN tumours in the TCGA cohort), and, accordingly, HER2 overexpression was seen exclusively in our CIN tumours (8/48, 16.7%). Here, EGFR is linked to neoplasm.